Furthermore, the increase in the activity of SOD, CAT, GR, and GPx along with the decrease in MDA levels indicated the suppression of oxidative stress by EA treatment compared to the NAFLD rats (p‐value < 0.0001). This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.